Editorial: High <scp>qHBsAg</scp>—Is it a good or bad signal? Authors' reply-Reference-Cited by-同舟云学术

Editorial: High qHBsAg—Is it a good or bad signal? Authors' reply

Published:2024-05-07 Issue:12 Volume:59 Page:1618-1619
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Lin Hsin‐Che¹²^ORCID,Jeng Wen‐Juei³⁴^ORCID,Yang Hwai‐I¹⁵⁶⁷^ORCID

Affiliation:

1. Genomics Research Center Academia Sinica Taipei Taiwan

2. Chang Gung Memorial Hospital, Linkou Taoyuan Taiwan

3. Department of Gastroenterology and Hepatology Chang Gung Memorial Hospital, Linkou Taoyuan Taiwan

4. Chang Gung University College of Medicine Taoyuan Taiwan

5. Institute of Clinical Medicine National Yang Ming Chiao Tung University Taipei Taiwan

6. Graduate Institute of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung Taiwan

7. Biomedical Translation Research Center Academia Sinica Taipei Taiwan

Abstract

LINKED CONTENTThis article is linked to Lin et al papers. To view these articles, visit https://doi.org/10.1111/apt.17915 and https://doi.org/10.1111/apt.17965.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.18021

Reference7 articles.

1. Editorial: high qHBsAg – is it a good or bad signal?;Kim BK;Aliment Pharmacol Ther,2024

2. Persistently high HBsAg levels during HBeAg‐seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients

3. High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

4. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis

5. Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B